登录新浪财经APP 搜索【信披】查看更多考评等级 上市公司名称:黑龙江珍宝岛药业股份有限公司 股票上市地点:上海证券交易所 截至本报告书签署之日，除本报告书披露的信息外，信息披露义务人没有通过任何其他方式增加或减少 其在黑龙江珍宝岛药业股份有限公司中拥有权益的股份。 股票简称：珍宝岛 股票代码：603567 信息披露义务人：黑龙江创达集团有限公司 住所/通讯地址：虎林市解放西街北检察院东侧宝润香林里1号楼1号门市 股份变动性质：股份减少 签署日期：2025年9月18日 信息披露义务人声明 一、本报告书系信息披露义务人依据《中华人民共和国证券法》《上市公司收购管理办法》《公开发行 证券的公司信息披露内容与格式准则第15号——权益变动报告书》等相关法律、法规和规范性文件编 制。 二、信息披露义务人签署本报告书已获得必要的授权和批准。 三、依据《中华人民共和国证券法》《上市公司收购管理办法》《公开发行证券的公司信息披露内容与 格式准则第15号——权益变动报告书》的规定，本报告书已全面披露信息披露义务人在黑龙江珍宝岛药 业股份有限公司中拥有权益的股份变动情况。 四、本次权益变动是根据本报告书所载明的资料进行的。信息披 ...

近日，黑龙江珍宝岛药业股份有限公司收到控股股东黑龙江创达集团有限公司通知，其2023年第一期可 交债"23创01EB"换股价格将调整。该债券于2023年4月11日发行，规模9.1亿元，期限3年。为保障持有 人利益，创达集团决定下调换股价格。8月11日董事会审议通过，20日债券持有人会议同意，换股价格 将从13.35元/股修正为12.35元/股，8月27日生效。下修后，质押专户预备股票仍满足换股需求。 ...

Group 1 - The core point of the announcement is that the controlling shareholder, Heilongjiang Chuangda Group Co., Ltd., has experienced a change in equity that touches the 1% threshold due to the conversion of exchangeable bonds and the repurchase of restricted shares by the company [1][2]. - As of August 1, 2025, Heilongjiang Chuangda Group's shareholding in the company decreased from 61.56% to 60.85%, following the conversion of 7,327,023 shares during the exchange period from November 8, 2023, to August 1, 2025 [1][2]. - The equity change does not result in a change of the controlling shareholder or actual controller of the company, nor does it trigger a mandatory tender offer [2][3]. Group 2 - The exchangeable bonds issued by Chuangda Group are currently in the conversion period, and the decision of bondholders to convert their bonds into shares is uncertain [4]. - The company will fulfill its information disclosure obligations in accordance with laws and regulations if any further equity changes occur [4].

Core Viewpoint - The announcement details a change in the equity stake of the controlling shareholder, Heilongjiang Chuangda Group Co., Ltd., in Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd., indicating a decrease in ownership percentage from 61.56% to 60.85% due to the repurchase and cancellation of restricted shares [1][2]. Group 1 - The controlling shareholder's equity stake decreased from 61.56% to 60.85% [1][2]. - The change in equity does not trigger mandatory tender offer obligations [1]. - The equity change is attributed to the repurchase and cancellation of restricted shares, which affected the total share capital of the company [2]. Group 2 - Heilongjiang Chuangda Group's shareholding decreased from 579,885,300 shares to 572,558,277 shares [1][2]. - The equity change occurred during the period of October 12, 2023, to December 8, 2023 [1]. - The company assures that the change in shareholding will not affect the status of the controlling shareholder or actual controller [2].